FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileSimplify Propel Opportunities ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
SURI
Simplify Propel Opportunities ETF ETF AnalysisComprehensive ETF analysis for Simplify Propel Opportunities ETF (SURI) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisSURI
SURI
Simplify Propel Opportunities ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
SURI
  1. Home
  2. Screener
  3. Simplify Propel Opportunities ETFSURIETF

Simplify Propel Opportunities ETF

ETF
🇺🇸SURI•AMEX•Equity
Fund size (USD)
$70.38M
Expense Ratio
2.84%
Yield (12 mo)
17.54%
Holdings
19

Your view on SURI

Simplify Propel Opportunities ETF

ETFSimplify
🇺🇸SURI•AMEX•Equity
Fund size (USD)
$70.38M
Expense Ratio
2.84%
Yield (12 mo)
17.54%
Holdings
19
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Simplify Propel Opportunities ETF (SURI) is an Equity fund from Simplify, listed since 2023, with $70.4M in assets under management, a 2.84% expense ratio and a NAV of $16.11 USD.

Overview for Simplify Propel Opportunities ETF

Fund Type
ETF
Fund Issuer
Simplify
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
February 7, 2023
Domicile
US
Website
simplify.us/etfs/suri-simplify-propel-opportunities-etf
Fund Type
ETF
Fund Issuer
Simplify
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
February 7, 2023
Domicile
US
Website
simplify.us/etfs/suri-simplify-propel-opportunities-etf
Fund Type
ETF
Fund Issuer
Simplify
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
February 7, 2023
Domicile
US
Website
simplify.us/etfs/suri-simplify-propel-opportunities-etf

About this fund

The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant op…

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

2.84%

Yield (12 mo)

17.54%

Fund size

$70.38M

Fund Details

NAV$16.11 USD
Holdings19
Average Volume4.5K
Inception DateFebruary 7, 2023
Asset ClassEquity
Fund IssuerSimplify
DomicileUS
ISINUS82889N6242
CUSIP82889N624
NAV CurrencyUSD

Expense Ratio

2.84%

Dividend Yield (TTM)

17.54%

Assets Under Management

$70.38M

NAV

$16.11 USD

Holdings

19

Average Volume

4.5K

Inception Date

February 7, 2023

Asset Class

Equity

Fund Issuer

Simplify

Domicile

US

ISIN

US82889N6242

CUSIP

82889N624

NAV Currency

USD

Expense Ratio

2.84%

Dividend Yield (TTM)

17.54%

Assets Under Management

$70.38M

NAV

$16.11 USD

Holdings

19

Average Volume

4.5K

Inception Date

February 7, 2023

Asset Class

Equity

Fund Issuer

Simplify

Domicile

US

ISIN

US82889N6242

CUSIP

82889N624

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 25, 2026Sep 30, 2026$0.68
Jun 25, 2026Jun 30, 2026$0.68
Mar 26, 2026Mar 31, 2026$0.68
Dec 23, 2025Dec 31, 2025$0.68
Total, 12 months$2.72 a share

Dividend yield (TTM) 17.54% = $2.72 paid per share in the 12 months to Nov 20, 2026 ÷ the $15.51 price. Past distributions; future payments can differ.

Data last updated: Nov 14, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

2 sectors
  • 1Energy
    53.4%
  • 2Healthcare
    46.6%

Top sector

Energy

Top weight

53.4%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

37 positions
1PAGPPLAINS GP HLDGS L P
32.71%
2SBILSIMPLIFY E GOVT MONEY MKT ETF
16.07%
3QUITACHIEVE LIFE SCIENCES INC USD 0.001
8.17%
4—Cash
7.38%
5DCTHDELCATH SYS INC USD 0.01
5.98%
6—ACHIEVE LIFE SCIENCES I WTS 30JUN30
4.14%
7COLLCOLLEGIUM PHARMACEUTICAL USD 0.001
3.52%
8OBIOORCHESTRA BIOMED HLDGS I USD 0.0001
2.53%
9MISTMILESTONE PHARMACEUTICALS INC NPV
2.00%
10CORTCORCEPT THERAPEUTICS INC USD 0.001
2.00%
11PHATPHATHOM PHARMACEUTICALS USD 0.0001
1.89%
12AQSTAQUESTIVE THERAPEUTICS IN USD 0.001
1.54%
13IVAINVENTIVA SA NPV ADR
1.40%
14—TELSAT 5.625 12/06/26 144A Corp
1.25%
15KYTXKYVERNA THERAPEUTICS IN USD 0.00001
1.19%

Concentration

Top 10 Weight84.50%
1PAGPPLAINS GP HLDGS L P
32.71%
2SBILSIMPLIFY E GOVT MONEY MKT ETF
16.07%
3QUITACHIEVE LIFE SCIENCES INC USD 0.001
8.17%
4—Cash
7.38%
5DCTHDELCATH SYS INC USD 0.01
5.98%
6—ACHIEVE LIFE SCIENCES I WTS 30JUN30
4.14%
7COLLCOLLEGIUM PHARMACEUTICAL USD 0.001
3.52%
8OBIOORCHESTRA BIOMED HLDGS I USD 0.0001
2.53%
9MISTMILESTONE PHARMACEUTICALS INC NPV
2.00%
10CORTCORCEPT THERAPEUTICS INC USD 0.001
2.00%
11PHATPHATHOM PHARMACEUTICALS USD 0.0001
1.89%
12AQSTAQUESTIVE THERAPEUTICS IN USD 0.001
1.54%
13IVAINVENTIVA SA NPV ADR
1.40%
14—TELSAT 5.625 12/06/26 144A Corp
1.25%
15KYTXKYVERNA THERAPEUTICS IN USD 0.00001
1.19%

Top 10 Weight

84.50%

1PAGPPLAINS GP HLDGS L P
32.71%$21.90M
2SBILSIMPLIFY E GOVT MONEY MKT ETF
16.07%$10.76M
3QUITACHIEVE LIFE SCIENCES INC USD 0.001
8.17%$5.47M
4—Cash
7.38%$4.94M
5DCTHDELCATH SYS INC USD 0.01
5.98%$4.00M
6—ACHIEVE LIFE SCIENCES I WTS 30JUN30
4.14%$2.77M
7COLLCOLLEGIUM PHARMACEUTICAL USD 0.001
3.52%$2.36M
8OBIOORCHESTRA BIOMED HLDGS I USD 0.0001
2.53%$1.69M
9MISTMILESTONE PHARMACEUTICALS INC NPV
2.00%$1.34M
10CORTCORCEPT THERAPEUTICS INC USD 0.001
2.00%$1.34M
11PHATPHATHOM PHARMACEUTICALS USD 0.0001
1.89%$1.27M
12AQSTAQUESTIVE THERAPEUTICS IN USD 0.001
1.54%$1.03M
13IVAINVENTIVA SA NPV ADR
1.40%$935.5K
14—TELSAT 5.625 12/06/26 144A Corp
1.25%$835.0K
15KYTXKYVERNA THERAPEUTICS IN USD 0.00001
1.19%$798.0K

Top 10 Weight

84.50%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
SURISimplify Propel Opportunities ETFThis fundEquity2.84%$70M19

Comparable funds

  • BCLOiShares BBB-B CLO Active ETFFixed Income0.45%$113M70
  • FDIVMarketDesk Focused U.S. Dividend ETFEquity0.35%$56M6
  • LCRLeuthold Core Exchange Traded FundAsset allocation0.83%$65M34
  • LFSCF/M Emerald Life Sciences Innovation ETFEquity0.79%$125M0
  • MVPAMiller Value Partners Appreciation ETFEquity0.60%$72M32
  • PSMOPacer Swan SOS Moderate (October) ETFEquity0.49%$120M6
  • RXLProShares - Ultra Health CareEquity1.08%$117M70
  • TSMYYieldMax TSM Option Income Strategy ETFAlternatives1.01%$95M12

More Simplify ETFs

  • MTBASimplify MBS ETFFixed Income0.28%$896M9
  • NMBSimplify National Muni Bond ETFFixed Income0.53%$47M68
  • NXTISimplify NEXT Intangible Core Index ETFEquity0.25%$14M199
  • PCRSimplify VettaFi Private Credit Strategy ETFAlternatives0.76%$2M0
  • PFIXSimplify Interest Rate Hedge ETFFixed Income0.53%$223M13
  • PINKSimplify Health Care ETFEquity0.51%$352M58
  • QISSimplify Multi-QIS Alternative ETFAlternatives1.13%$42M3,518
  • RFIXSimplify Bond Bull ETFFixed Income0.50%$41M11
  • SBARSimplify Barrier Income ETFEquity Income0.87%$441M5
  • SBILSimplify Government Money Market ETFFixed Income0.15%$4.0B7
  • SDMFSimplify DBi CTA Managed Futures Index ETFAlternatives0.21%$62M2
  • SPBCSimplify US Equity PLUS Bitcoin Strategy ETFEquity0.53%$42M5
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.